Nebulizer vs inhaler: which delivers asthma relief faster?

NCT ID NCT05977699

Completed Symptom relief Sponsor: University of Saskatchewan Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested two methods of giving salbutamol (a common asthma rescue drug) to 16 adults with mild asthma. One method used a vibrating mesh nebulizer, the other a standard inhaler with a spacer. The goal was to see which one reversed airway narrowing faster and more completely. Results will help guide choices for delivering quick relief during asthma attacks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: salbutamol
What this could lead to: If successful, this could show that a vibrating mesh nebulizer works as well as or better than a standard inhaler for quickly reversing asthma symptoms.
What could go wrong: This is a very small, early-phase study with only 16 people, so results may not apply to everyone. It only looks at short-term lung function, not long-term outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASTHMA

Contacts and locations

Locations

Asthma Research Lab University of Saskatchewan Room 346 Ellis Hall

Saskatoon, Saskatchewan, S7N 0W8, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.